Table 4.
Among patients identified with an alcohol or drug use disorder (AOD) in an inpatient setting who initiated AOD treatment (N=16,193), characteristics associated with AOD treatment engagement
Characteristic associated with AOD treatment engagement | Identified in inpatient setting (N=16193) N (%) or Median (IQR) | Unadjusted RR for AOD engagement (95% CI) | Adjusted RR for AOD engagement (95% CI) |
---|---|---|---|
Race/ethnicity | |||
White | 10012 (61.8) | [Ref] | [Ref] |
Asian | 549 (3.4) | 1.10 (0.78–1.55) | 1.22 (0.85–1.76) |
African American | 1941 (12.0) | 0.61 (0.47–0.78) | 0.68 (0.56–0.82) |
Hispanic | 2732 (16.9) | 0.97 (0.88–1.08) | 1.02 (0.93–1.13) |
Other/Unknown | 959 (5.9) | 1.07 (0.84–1.36) | 1.13 (0.91–1.42) |
Age | 53.0 (19.0) | 0.98 (0.98–0.99) | -- |
Sex | |||
Male | 9471 (58.5) | [Ref] | [Ref] |
Female | 6722 (41.5) | 0.91 (0.78–1.08) | 0.91 (0.77–1.08) |
Charlson/Deyo comorbidity index | |||
0 | 6043 (37.3) | [Ref] | [Ref] |
1 | 3273 (20.2) | 0.95 (0.84–1.07) | 0.90 (0.79–1.02) |
2+ | 6877 (42.5) | 0.73 (0.64–0.83) | 0.70 (0.61–0.79) |
Diagnoses in the prior year | |||
Alcohol Dependence | 3843 (23.7) | 2.68 (2.28–3.16) | 2.70 (2.23–3.26) |
Drug Dependence | 2998 (18.5) | 1.96 (1.79–2.15) | -- |
Depressive Disorder | 6093 (37.6) | 1.45 (1.31–1.62) | 1.37 (1.23–1.52) |
Major Psychotic Disorder | 2823 (17.4) | 1.59 (1.31–1.92) | 1.47 (1.15–1.88) |
Tobacco Dependence | 5070 (31.3) | 1.51 (1.35–1.68) | -- |
Hepatitis C | 588 (3.6) | 1.44 (1.10–1.86) | -- |
Pancreatic Disease | 971 (6.0) | 1.58 (1.44–1.74) | -- |
Abbreviations. IQR=interquartile range; RR = risk ratio; CI = confidence interval; AOD=alcohol or other drugs; -- indicates variables not included in adjusted analyses because they either were not significant in bivariate analyses (p-value ≥ 0.25) or forward selection modeling (p-value ≥ 0.25)